Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Clinicopathologic study on cholangiolocellular carcinoma.

K Shiota1, J Taguchi, O Nakashima

  • 1Department of Pathology, Kurume University School of Medicine, Kurume 830-0011, Japan. koji@med.kurume-u.ac.jp

Oncology Reports
|February 22, 2001
PubMed
Summary

Cholangiolocarcinoma (CLC) presents clinical signs similar to hepatocellular carcinoma (HCC) but exhibits morphological characteristics of cholangiocarcinoma (CCC). This suggests CLC may originate from hepatic stem cells.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Phase II trial of combination treatment with paclitaxel, carboplatin and cetuximab (PCE) as first-line treatment in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck (CSPOR-HN02).

Annals of oncology : official journal of the European Society for Medical Oncology·2018
Same author

Dismal outcome of allogeneic hematopoietic stem cell transplantation for relapsed adult T-cell leukemia/lymphoma, a Japanese nation-wide study.

Bone marrow transplantation·2017
Same author

Thymoma-associated multi-organ autoimmunity: two cases and a review of the literature.

Journal of the European Academy of Dermatology and Venereology : JEADV·2017
Same author

Sinusoidal obstruction syndrome after allogeneic hematopoietic stem cell transplantation: Incidence, risk factors and outcomes.

Bone marrow transplantation·2015
Same author

Early application of related SCT might improve clinical outcome in adult T-cell leukemia/lymphoma.

Bone marrow transplantation·2015
Same author

Effect of the order of TBI and cyclophosphamide administration on the outcome of allogeneic hematopoietic stem cell transplantation.

Bone marrow transplantation·2015

Area of Science:

  • Hepatobiliary pathology
  • Gastroenterology
  • Surgical oncology

Background:

  • Cholangiolocarcinoma (CLC) is a rare primary liver cancer.
  • Understanding CLC's distinct clinicopathological features is crucial for accurate diagnosis and treatment.

Purpose of the Study:

  • To investigate the clinicopathological characteristics of resected cholangiolocarcinoma (CLC).
  • To differentiate CLC from hepatocellular carcinoma (HCC) and cholangiocarcinoma (CCC).

Main Methods:

  • Clinicopathological analysis of 6 resected cholangiolocarcinoma (CLC) cases.
  • Immunohistochemical staining for cytokeratins (CK7, CK8).
  • Comparison of clinical, gross, and histological findings with known liver cancer types.

Related Experiment Videos

Main Results:

  • CLC occurred in 0.56% of primary liver cancer resections, with a mean age of 66.
  • Clinically, CLC mimicked HCC, but morphologically resembled CCC.
  • Tumor cells showed Hering's canal-like gland proliferation and were positive for CK7 and CK8.

Conclusions:

  • Cholangiolocarcinoma (CLC) exhibits a unique presentation, clinically resembling hepatocellular carcinoma (HCC) yet morphologically aligning with cholangiocarcinoma (CCC).
  • The findings suggest a potential origin from hepatic stem cells or Hering's canal cells, possessing intermediate differentiation characteristics.